CAS: 2163056-91-3
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
2-(4-(4-(Isoquinolin-4-yl)phenyl)-1H-pyrazol-1-yl)-N,N-dimethylacetamide REF: AN-AG01K8N6CAS: 2163056-91-3 | 99+% | 147,00 €~1.913,00 € | Mar 07 May 24 | |
BI-1347 REF: TM-T5405CAS: 2163056-91-3 | 99.43% | 40,00 €~1.328,00 € | Mar 14 May 24 | |
BI-1347 REF: 3D-NLD05691CAS: 2163056-91-3 | Min. 95% | A consultar | Mar 18 Jun 24 |
2-(4-(4-(Isoquinolin-4-yl)phenyl)-1H-pyrazol-1-yl)-N,N-dimethylacetamide
CAS:2163056-91-3
Fórmula:
C22H20N4O
Pureza:
99+%
Forma y color:
Solid
Peso molecular:
356.4204
Ref: AN-AG01K8N6
5mg | 147,00 € | |
10mg | 232,00 € | |
100mg | 1.913,00 € |
Entrega estimada en Estados Unidos, el Martes 7 de Mayo de 2024
BI-1347
CAS:2163056-91-3
BI-1347 is a potent, selective inhibitor of CDK8/cyclinC (IC50: 1 nM). It shows tumor growth …
Fórmula:
C22H20N4O
Pureza:
99.43%
Forma y color:
Solid
Peso molecular:
356.42
Ref: TM-T5405
1mg | 40,00 € | |
5mg | 86,00 € | |
10mg | 123,00 € | |
25mg | 235,00 € | |
50mg | 430,00 € | |
100mg | 634,00 € | |
500mg | 1.328,00 € | |
1ml*10 (DMSO) | 96,00 € |
Entrega estimada en Estados Unidos, el Martes 14 de Mayo de 2024
BI-1347
CAS:2163056-91-3
BI-1347 is a small molecule that has been shown to be effective in the treatment …
Fórmula:
C22H20N4O
Pureza:
Min. 95%
Peso molecular:
356.42 g/mol
Ref: 3D-NLD05691
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar | |
100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 18 de Junio de 2024